More than 75 percent of primary care physicians in the United States who order or perform the fecal occult blood test as a screening option for colorectal cancer perform an in-office test rather than ...

TO THE EDITORS:In the July issue of The American Journal of Managed Care, Schroy et al 1 reported on preferences for colorectal cancer (CRC) screening tests in relation to currently recommended ...

Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim: To asess ...

Routine screening with fecal occult blood testing (FOBT) is associated with a decrease in colorectal cancer (CRC) mortality, according to a study published online Feb. 27 in JAMA Network Open.

Fecal occult-blood testing (FOBT) is a noninvasive, effective means of screening for colorectal cancer (CRC). The SENSITIVITY of this technique is suboptimal, however, and identification of a simple, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. After a maximum follow-up of 14 years, the mean ...

Background and Aim: To investigate the participation rates, positivity rates, and follow-up rates from 2004 to 2008 in an organized colorectal cancer (CRC) screening program using a fecal occult blood ...

The inexpensive tests that look for hidden blood in a person's stool are effective for colon cancer screening, a study confirms. The findings, reported in the Canadian Medical Association Journal, ...

Abnormal results of guaiac fecal occult blood testing (FOBT) may flag a higher mortality risk that extends beyond death from colorectal cancer, a Scottish study showed. The study, which had as much as ...

Objective: To assess patient preferences for 1 of the recommended colorectal cancer screening options or stool DNA testing (sDNA), a novel noninvasive screening test. Study Design: Cross-sectional ...